Spark Therapeutic, for example cures retinal diseases, genetic mutations, rare diseases, and so we said, Lets try to do this with a drug, or at least a system of a drug thats approved. So we packaged up those three genes, we put them under the control of an antibiotic, doxycyline, and now we could put them into the eye, or anywhere really, and then turn the genes on when we wanted to, to ask the following: if we damage the retina or the optic nerve, and then turn on our reprogramming and make the eye young, well, first of all, does it become young
Antioxidant defense mechanisms keep the formed ROS at a low level nevertheless heavy metal stress disrupts the equilibrium between ROS generation and detoxification (Sharma and Dietz 2009)
In Kazakhstan, the rehabilitation of L-C19 patients is provided mainly in hospitals, particularly for those with severe manifestations of L-C19 symptoms that include immune deficiency conditions, cognitive disorders, progression of atherosclerosis and exacerbation of hypertension (209)
Duchenne muscular dystrophy
Graves disease: Graves disease is another autoimmune condition of the thyroid characterized by the production of TSIs that acts on TSH receptors found on the plasma membrane of thyroid follicular cells, triggering an excessive response by inducing a surge in secretion that eventually causes hyperthyroidism (Bartalena et al
Gilbert Hosts , I spoke with Dr
